Comparison of the topical ocular antiallergic efficacy of emedastine 0.05% ophthalmic solution to ketorolac 0.5% ophthalmic solution in a clinical model of allergic conjunctivitis

Acta Ophthalmologica Scandinavica, Supplement

Volumn 77, Issue 228, 1999, Pages 43-46

  Discepola, M ^a   Deschenes, J ^a   Abelson, M ^b  

^a ROYAL VICTORIA HOSPITAL   (Canada)

^b Ophthalmic Research Associates   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; EMEDASTINE; EYE DROPS; KETOROLAC; KETOROLAC TROMETAMOL; UNCLASSIFIED DRUG; BENZIMIDAZOLE DERIVATIVE; HISTAMINE H1 RECEPTOR ANTAGONIST; NONSTEROID ANTIINFLAMMATORY AGENT;

ALLERGIC CONJUNCTIVITIS; CILIARY BODY EPITHELIUM; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CONJUNCTIVA; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; EXPERIMENTAL MODEL; HUMAN; HYPEREMIA; INFLAMMATION; INTRAOCULAR DRUG ADMINISTRATION; PATIENT SATISFACTION; PRIORITY JOURNAL; PROVOCATION TEST; PRURITUS; RANDOMIZED CONTROLLED TRIAL; SCLERA; STATISTICAL ANALYSIS; ARTICLE; COMPARATIVE STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; TREATMENT OUTCOME;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BENZIMIDAZOLES; CONJUNCTIVITIS, ALLERGIC; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; HISTAMINE H1 ANTAGONISTS; HUMANS; KETOROLAC; OPHTHALMIC SOLUTIONS; TREATMENT OUTCOME;

EID: 0032586305     PISSN: 13953931     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0420.1999.tb01173.x     Document Type: Conference Paper

References (11)

1. Abelson MB, George MA & Garafalo C (1993): Differential diagnosis of ocular disorders. Ann Allergy 70: 95-113.
2. Miller J & Wolf EH (1975): Antazoline phosphate and naphazoline hydrochloride, singly and in combination for the treatment of allergic conjunctivitis - a controlled, double-blind clinical trial. Ann Allergy 35: 81-86.
3. Abelson MB, Paradis A, George MA & Smith LM (1990): Ther effects of Vasocon-A in the allergen challenge model of acute conjunctivitis. Arch Ophthalmol 108: 520-524.
4. Abelson MB, Allansmith MR & Friedlander MH (1980): Effects of topically applied ocular decongestant and antihistamine. Am J Ophthalmol 90: 254-257.
5. Abelson MB, Chambers WA & Smith LM (1990): Conjunctival allergen challenge: a clinical approach to studying allergic conjunctivitis. Arch Ophthalmol 108: 84-88.
6. 1 antagonist for topical ocular use. J Ocul Pharmacol Ther 10: 665-675.
7. Woodward DF, Nieves L, Hawley SB, Joseph R, Merlino GF & Spada CS (1995): The pruritigenic and inflammatory effects of prostanoids in the conjunctiva. J Ocul Pharmacol Ther 11: 339-347.
8. Berdy GJ, Abelson MB, George MA, Smith LM & Giovanoni RL (1991): Allergic conjunctivitis: a survey of new antihistamines. J Ocul Pharmacol Ther 7: 313-324.
9. Deschenes J, Discepola M, Abelson MB (1999): Comparative evaluation of olopatadine ophthalmic solution (0.1%) versus ketorolac ophthalmic solution (0.5%) using the provocative antigen challenge model. Acta Ophthalmol CURRENT ISSUE.
10. Ballas Z, Blumenthal M, Tinkelman DG, Kriz R & Rupp G (1993): Clinical evaluation of ketorolac tromethamine 0.5% ophthalmic solution for the treatment of seasonal allergic conjunctivitis. Surv Ophthalmol 38: 141-148.
11. Tinkelman DG, Rupp G, Kaufman H, Pugely J & Schultz N (1993): Double-masked, paired-comparison clinical study of ketorolac tromethamine 0.5% ophthalmic solution compared with placebo eyedrops in the treatment of seasonal allergic conjunctivitis. Surv Ophthalmol 38: 133-140.